Melar Acquisition Corp. I Class A MACI 深 沪
等待开盘 09-26 09:30:00 美东时间
10.55
0.000
0.00%
华盛通- 最 高0.00
- 今 开10.55
- 成交量 78股
- 最 低 0.00
- 昨 收 10.55
- 总市值 2.28亿
- 52周最高 10.8294
- 市盈率 静 54.19
- 换手率 0.00%
- 52周最低 9.95
- 委 比 22.88%
- 总股本 2162.16万
- 历史最高 10.8294
- 量 比 0
- 振 幅 0.00%
- 历史最低 9.95
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Melar Acquisition Corp. I Secures Increased Funding
Melar Acquisition Corp. I Class A ( ($MACI) ) has issued an announcement. On Au...
09-19 04:59
Everli To Go Public Via SPAC Merger With Melar, To Trade On Nasdaq Under Ticker "EVRL"
Everli is transforming the online grocery shopping experience in Italy, offering a user-friendly platform that connects consumers with their favorite local retailers for convenient doorstep delivery through their vast
07-31 21:04
Vericel Reaffirms Full-year 2025 Profitability Guidance Of Gross Margin Of 74% And Adjusted EBITDA Margin Of 26%
2025 Financial GuidanceReaffirmed MACI full-year revenue growth in the low 20% rangeUpdated Burn Care revenue guidance for the second half of 2025 to be in line with recent run rate of approximately $10 million per
07-31 20:11
What Analysts Are Saying About Vericel Stock
In the last three months, 4 analysts have published ratings on Vericel (NASDAQ:...
05-23 06:00
What 7 Analyst Ratings Have To Say About Vericel
Ratings for Vericel (NASDAQ:VCEL) were provided by 7 analysts in the past three...
02-03 21:01
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
Throughout the last three months, 5 analysts have evaluated Vericel (NASDAQ:VCE...
01-15 21:01
Vericel expects 2024 net revenue in range of $237 to $237.5 million
Vericel Corporation (NASDAQ:VCEL) on Tuesday said its FY 2024 net revenue expected to be about $237 to $237.5 million, compared to consensus revenue estimates of $239.76 million. MACI net revenue expe...
01-15 05:27
Earnings Preview For Vericel
Vericel (NASDAQ:VCEL) is preparing to release its quarterly earnings on Thursda...
2024-11-07 01:01
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
In the preceding three months, 7 analysts have released ratings for Vericel (NA...
2024-08-28 02:00
Vericel announces FDA approval, commercial availability of MACI Arthro
Vericel (NASDAQ:VCEL) has announced that the U.S. FDA has approved a supplemental Biologics License Application expanding the MACI® label to include arthroscopic delivery of MACI to repair symptomatic...
2024-08-26 19:54
